Design and development of a self correcting monolithic gastroretentive tablet of baclofen

Scientia Pharmaceutica

Volumn 77, Issue 3, 2009, Pages 651-667

  Jivani, Rishad R ^a   Patel, Chhagan N ^b   Jivani, Nuruddin P ^a  

^a Smt RBPatel Mahila Pharmacy College   (India)

^b Shari Sarvajanik Pharmacy College   (India)

Author keywords

Baclofen; Gastro retentive drug delivery system; Polyethylene oxide (PEO); Simplex lattice design

Indexed keywords

BACLOFEN; BICARBONATE; MACROGOL;

ARTICLE; DRUG DESIGN; DRUG FORMULATION; DRUG RELEASE; DRUG SOLUBILITY; PHYSICAL CHEMISTRY; TABLET COMPRESSION;

EID: 70349284767     PISSN: 00368709     EISSN: 22180532     Source Type: Journal    
DOI: 10.3797/scipharm.0905-11     Document Type: Article

References (34)

1. Colombo P, Bettini R, Santi P, Peppas NA. Swellable matrices for controlled drug delivery: gel layer behavior, mechanism and optimal performance. Pharm Sci Technol Today. 2000; 3: 198-204. doi:10.1016/S1461-5347(00)00269-8 (Pubitemid 30364933)
2. Baumgartner S, Kristi J, Vrecer F, Vodopivec P, Zorko B. Optimization of floating matrix tablets and evaluation of their gastric residence time. Int J Pharm. 2000; 195: 125-135. doi:10.1016/S0378-5173(99)00378-6 (Pubitemid 30089497)
3. Iannuccelli V, Coppi G, Bernabei MT, Cameroni R. Air compartment multiple-unit system for prolonged gastric residence. Part I. Formulation study. Int J Pharm. 1998; 174: 47-54. doi:10.1016/S0378-5173(98)00229-4 (Pubitemid 28486988)
4. Santus G, Lazzarini G, Bottoni G. An in vitro-in vivo investigation of oral bioadhesive controlled release furosemide formulations. Eur J Pharm Biopharm. 1997; 44: 39-52. doi:10.1016/S0939-6411(97)00100-8 (Pubitemid 28298774)
5. Deshpande AA, Rhodes CT, Shah NH, Malick AW. Controlled-release drug delivery systems for prolonged gastric residence: an overview. Drug Dev Ind Pharm. 1996; 22: 531-540. doi:10.3109/03639049609108355
6. Deshpande AA, Shah NH, Rhodes CT, Malick W. Development of a novel controlled-release system for gastric retention. Pharm Res. 1997; 14: 815-819. doi:10.1023/A:1012171010492 (Pubitemid 27281680)
7. Menon A, Ritschel WA, Sakr A. Development and evaluation of a monolithic floating dosage form for furosemide. J Pharm Sci. 1994; 83: 239-245. doi:10.1002/jps.2600830225 (Pubitemid 24224185)
8. Whitehead L, Fell JT, Collett JH, Sharma HL, Smith AM. Floating dosage forms: an in vivo study demonstrating prolonged gastric retention. J Control Rel. 1998; 55: 3-12. doi:10.1016/S0168-3659(97)00266-6 (Pubitemid 28477559)
9. Singh B, Kim K. Floating drug delivery systems: an approach to oral controlled drug delivery via gastric retention. J Control Rel. 2000; 63: 235-259. doi:10.1016/S0168-3659(99)00204-7
10. Chawla G, Bansal A. A means to address regional variability in intestinal drug absorption. Pharm Technol. 2003; 27: 50-68. (Pubitemid 37101890)
11. Pillay V, Fassihi R. Electrolyte-induced compositional heterogeneity: A novel approach for rate-controlled oral drug delivery. J Phrm Sci. 1999; 88: 1140-1148. doi:10.1021/js9901054 (Pubitemid 29526299)
12. Jeong B, Kim SW, Bae YH. Thermo sensitive sol-gel reversible hydrogels. Adv Drug Deliv Rev. 2002; 54: 37-51. doi:10.1016/S0169-409X(01)00242-3 (Pubitemid 34075313)
13. Dhawan S, Dhawan K, Varma M, Sinha VR. Application of poly (ethylene oxide) in drug delivery systems. Pharm Technol. 2005; 29: 72. (Pubitemid 41285904)
14. Levina M, Rajabi AR. The influence of excipients on drug release from HPMC. J Pharm Sci. 2004; 93: 2746-2754. doi:10.1002/jps.20181
15. Bravo SA, Lamas MC, Salomon CJ. Swellable matrices for the controlled release of diclofenac sodium: formulation and in-vitro studies. Pharm Dev Technol. 2004; 9: 75-83. doi:10.1081/PDT-120027420
16. Pillay V, Fassihi R. A novel approach for constant rate delivery of highly soluble bioactives from a simple monolithic system. J Control Rel. 2000; 67: 67-78. doi:10.1016/S0168-3659(00)00193-0 (Pubitemid 30201682)
17. Ali J, Arora S, Ahuja A, Babbar AK, Sharma RK, Khar RK. Formulation and Development of Floating Capsules of Celecoxib: In Vitro and In Vivo Evaluation. AAPS PharmSciTech. 2007; 8: E119-E126. doi:10.1208/pt0802045
18. Lee B, Ryu S, Cui JH. Formulation and release characteristics of hydroxypropylmethylcellulose matrix tablet containing melatonin. Drug Dev Ind Pharm. 1999; 25: 493-501. doi:10.1081/DDC-100102199 (Pubitemid 29159428)
19. Kader A, Jalil R. Formulation factors affecting drug release from poly(lactic-acid)(PLA) microcapsule tablets-Drug Dev Ind Pharm. 1999; 25: 141-151. doi:10.1081/DDC-100102154
20. Devis SS. Formulation strategies for absorption windows. Drug Discov Today. 2005; 10: 249-257. doi:10.1016/S1359-6446(04)03351-3
21. Ahuja S. Analytical Profiles of Drug substances Volume14. London: Elsevier Publisers. 1985: 527-547.
22. Hamdy A, Ossama YA, Hesham S. Formulation of Controlled-Release Baclofen Matrix Tablets: Influence of Some Hydrophilic Polymers on the Release Rate and In Vitro Evaluation. AAPS PharmSciTech. 2007; 8: 156-166. doi:10.1208/pt0804100
23. Wan LSC, Heng PWS, Wong LF. Matrix swelling: A simple model describing extent of swelling of HPMC matrices. Int J Pharm.1995; 116: 159-168. doi:10.1016/0378-5173(94)00285-D
24. Ju RTC, Nixon PR, Patel MV. Diffusion coefficients of polymer chains in the Diffusion layer adjustments to a swollen hydrophilic matrix. J Pharm Sci. 1997; 86: 1293-1298. doi:10.1021/js970053n
25. th ed., 1990; Volume 135: 523-531.
26. Singh B, Ahuja N. Development of controlled-release buccoadhesive hydrophilic matrices of diltiazem hydrochloride: Optimization of bioadhesion, dissolution, and diffusion parameters. Drug Dev Ind Pharm. 2002; 28: 431-442. doi:10.1081/DDC-120003004 (Pubitemid 34552236)
27. Higuchi T. Mechanism of sustained-action medication: theoretical analysis of rate of release of solid drugs dispersed in solid matrices. J Pharm Sci. 1963; 52: 1145-1149. doi:10.1002/jps.2600521210
28. Hixon AW, Crowell JH. Dependence of reaction velocity upon surface and agitation. Ind Eng Chem. 1931; 23: 923-931. doi:10.1021/ie50260a018
29. Korsmeyer R, Gurny R, Peppas N. Mechanisms of solute release from porous hydrophilic polymers. Int J Pharm. 1983; 15: 25-35. doi:10.1016/0378-5173(83) 90064-9
30. Peppas NA. Analysis of Fickian and non-Fickian drug release from polymers. Pharm Acta Helv. 1985; 60: 110-111. PMid:4011621
31. Harland RS, Gazzaniga A, Sangalli ME, Colombo P, Peppas NA. Drug/polymer matrix: swelling and dissolution. Pharm Res. 1988; 5: 488-494. doi:10.1023/A:1015913207052
32. Langenbucher F. Linearization of dissolution rate curves by the Weibull distribution. J Pharm Pharmacol. 1972; 24: 979-981. PMid:4146531
33. Goldsmith JA, Randall N, Ross SD. Methods of expressing dissolution rate data. J Pharm Pharmacol. 1978; 30: 347-349. PMid:26763 (Pubitemid 8350925)
34. Bamba M, Puisieux F. Release mechanisms in gel forming sustained release preparation. Int J Pharm. 1979; 2: 307-315. doi:10.1016/0378-5173(79)90037-1 (Pubitemid 9161631)